Evidence map›Paper›PMID 42627329›Full record

ArticleChemSusChem2026

Scalable Synthesis of Sulfonated TEMPO Catholyte for Stable AORFB.

Hongbiao Zhu, Dezhi Ou, Tinghao Zhang, Zhipeng Ye, Jiaming You, Leyang Lv, Yanlin Shi, Yongmiao Shen, Jianyu Cao, Kai Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hongbiao ZhuSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, P. R. China.
Dezhi OuSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, P. R. China.ORCID https://orcid.org/0009-0000-1482-4420
Tinghao ZhangSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, P. R. China.
Zhipeng YeSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, P. R. China.
Jiaming YouSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, P. R. China.
Leyang LvSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, P. R. China.
Yanlin ShiSchool of Materials Science and Engineering, Hunan University of Science and Technology, Xiangtan, P. R. China.ORCID https://orcid.org/0000-0003-3596-6748
Yongmiao ShenSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, P. R. China.ORCID https://orcid.org/0000-0002-9382-9744
Jianyu CaoJiangsu Key Laboratory of Advanced Catalytic Materials and Technology, School of Petrochemical Engineering, Changzhou University, Changzhou, P. R. China.ORCID https://orcid.org/0000-0003-2716-7663
Kai ZhangSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, P. R. China.ORCID https://orcid.org/0000-0003-1966-458X

Funding

National Natural Science Foundation of China 21062371-Athe Science Foundation of Zhejiang Sci-Tech University 20062099-YZhejiang Provincial Natural Science Foundation of China LY23B040004
6 · The paper itself

Abstract

The development of chemically robust and synthetically accessible redox-active organics is paramount for the advancement of sustainable aqueous organic redox flow batteries (AORFBs). While TEMPO derivatives are premier catholyte candidates, their practical utility is frequently hampered by complex, multistep synthesis and the susceptibility of the charged oxoammonium state to irreversible ring-opening degradation. We novelly provide HOTEMPO-SO

Indexed as

AORFBscalable synthesisTEMPO derivatives

Identifiers

PMID42627329
PMCPMC13496052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.